Click to Share
 
 
  1. Latest News
  2. Submit Press Release
Filter News
Show All Results
News By Country
News By Tag
Immune Response BioPharma Inc. Remove


April 2015
Su Sa Fr Th We Tu Mo
26 25 24 23 22 21 20

Immune Response BioPharma Inc. Press Releases

  + XML/RSS  



By Immune Response BioPharma, Inc.
Immune Response BioPharma, Inc. to Develop in house Sales-Force for Blockbuster REMUNE HIV/AIDS Vaccine Commercialization
By Immune Response BioPharma, Inc.
Immune Response BioPharma, Inc. Announces the FDA SBA BLA Fee Waiver has been Granted & Clears a Path for the REMUNE HIV/AIDS Vaccine Approval
By Immune Response BioPharma, Inc.
Immune Response BioPharma, Inc. Announces NeuroVax Granted Fast Track FDA Designation for SPMS
By Immune Response BioPharma, Inc.
Immune Response BioPharma, Inc. to Develop Zorcell Psoriasis Vaccine the First Vaccine for Psoriasis & Reviews Phase II Results

All Press Releases

By Immune Response BioPharma, Inc.
Immune Response BioPharma, Inc. to Develop in house Sales-Force for Blockbuster REMUNE HIV/AIDS Vaccine Commercialization
By Immune Response BioPharma, Inc.
Immune Response BioPharma, Inc. Announces the FDA SBA BLA Fee Waiver has been Granted & Clears a Path for the REMUNE HIV/AIDS Vaccine Approval
By Immune Response BioPharma, Inc.
Immune Response BioPharma, Inc. Announces NeuroVax Granted Fast Track FDA Designation for SPMS
By Immune Response BioPharma Inc.
Immune Response BioPharma, Inc. Posts 2nd Half & Full Year 2013 Results
By Immune Response BioPharma, Inc.
Immune Response BioPharma, Inc. to Develop Zorcell Psoriasis Vaccine the First Vaccine for Psoriasis & Reviews Phase II Results
By Immune Response BioPharma, Inc.
Immune Response BioPharma, Inc. Files for Orphan Designation of Blockbuster RA Vaccine RAVAX for expanded use into the rare disease Juvenile Rheumatoid Arthritis.
By Immune Response BioPharma, Inc.
Immune Response BioPharma, Inc. Files for Orphan Designation for Blockbuster Drug NeuroVax for Multiple Sclerosis
By Immune Response BioPharma, Inc.
Immune Response BioPharma, Inc. Announces Formulation Changes to Blockbuster RA Drug RAVAX Adds 4th Peptide for Potent RA Vaccine


Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share